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Introduction
Severe Traumatic Brain Injury (S-TBI) is the major cause of mortality, morbidity, and disability among people younger than 45 years old. It constitutes a major problem in developed countries, not only for the affected patients and their families but also for the society, with serious socio-economic ramifications. It cannot be overemphasized the society's burden from S-TBIs, which may exhaust even the most developed health care systems. During the last 30 years, advances in pre-hospital treatment, novel imaging modalities, intensive care monitoring improvements, rehabilitation advances, as well as better understanding of the S-TBI pathophysiology have decreased the overall mortality rate from 70-80% in 1970's to 30 % nowadays. Severe TBI is still associated with unfavorable outcome (death or severe disability) in up to 60%. Continuous efforts of the neurosurgical community focus not only on decreasing the S-TBI associated mortality, but also on improving the quality of life and the functional outcome of patients suffering S-TBIs [Danish, et al., 2009; Honeybul, et al., 2011] . It has been demonstrated by Marmarou and his colleagues [Marmarou et al., 1991] that increased intracranial pressure (ICP) is strongly associated with poor outcome in patients suffering S-TBIs, making thus intracranial hypertension the most frequent cause of death and disability. Moreover, it has been postulated that this association between increased ICP and poor outcome is linear. Frequently, the greatest challenge for a neurosurgeon treating a patient suffering a S-TBI is the management of increased ICP, which in a large number of cases overwhelms brain's ability to regulate cerebral blood flow (CBF), resulting thus to cerebral ischemia and consequently to severe disability and/or death. Elevated ICP is usually defined as an ICP above a threshold of 20 mmHg, measured within any intracranial space (subdural, intraventricular, extradural or intraparenchymal compartments). The cause of increased ICP in patients with S-TBIs is the result of an increase in brain parenchyma volume at the expense of one or more of the other two intracranial components (cerebral blood volume, cerebral spinal fluid). An increase in brain water content (edema), increased cerebral blood volume, and /or the presence of hematomas contribute significantly to increases of ICP in patients with S-TBI. It has been proposed that the employment of DC may drastically lower the increased ICP by allowing expansion of the edematous cerebral hemispheres. Furthermore, it has been postulated that DC interrupts the vicious cycle of intracranial hypertension via the impairment of the cerebral perfusion pressure (CPP), which inevitably results into further ICP increasing and may eventually lead to cellular injury and death. In this chapter the historical evolution of the surgical technique of DC is presented along with a brief description of the various surgical types and techniques, which are currently utilized in clinical practice. Moreover, the current concepts and controversies, the ongoing clinical trials, and the procedure associated complications are presented and discussed.
Decompressive craniectomy: Historical landmarks
Decompressive craniectomy has been proposed for many years as a valid treatment option for severe medically refractory intracranial hypertension, caused by various pathological conditions such as, S-TBIs, extensive cerebral infraction, massive subarachnoid hemorrhage, large intraparenchymal hemorrhage, severe intracranial infections, and extensive venous sinus thrombosis. Hippocrates was the first who clearly described the indications for trephination in severe head injuries. Indeed, trephination remained for centuries the major surgical intervention for managing patients with severe closed head injuries. The concept of decompression (removal of a variable amount of calvaria) was introduced in the late 1890 by Annandale. Kocher in 1901 proposed the opening of the skull for relieving increased intracranial pressure, while Harvey Cushing [Cushing, 1905] performed a subtemporal decompressive craniectomy for treating moribund edema caused by an intracranial neoplastic disorder. The concept of large cranial and dural decompression along with the removal of any underlying masses was initially described by Miyazaki in 1966, while Kjellberr and Prieto refined this surgical technique in 1971. For decades, DC was known as an occasionally life saving procedure, associated however with numerous serious complications. Therefore, the vast majority of neurosurgeons were not very eager in incorporating DC in the trauma neurosurgical armamentarium. Characteristically, Clarke in 1968 stated that the only reason for reporting his experience from performing DCs in S-TBI patients was for warning other neurosurgeons to avoid performing similar surgery. Decompressive craniectomy in its current form was recently re-introduced by Guerra and his coworkers [Guerra et al., 1999] , who reported favorable outcome in more than 50% of their cases, undergoing DC after suffering S-TBIs. Since then, many non-randomized, usually retrospective, and small size clinical studies have suggested that DC may be a valuable treatment option, when maximal medical treatment has failed to control increased ICP. It has to be pointed out that the number of the published articles in the medical literature regarding the role of DC in the management of patients with S-TBI has been geometrically increased during the last decade ( Fig. 1 ). However, the pertinent literature demonstrates a wide variation in clinical outcomes, and ill-defined indications for performing DC in patients with S-TBIs [Aarabi et al., 2006; Howard et al., 2008; Jagannathan, et al., 2007; Morgalla et al., 2008; Münch et al., 2000] . 
Types of surgical decompression and surgical procedures
Historically, DC is defined as the removal of different parts and portions of the skull, with or without opening of the underlying dura, and augmentative duroplasty. A variety of operations have been proposed and different surgical techniques have been developed for brain decompression. These include: a) the classic and widely used fronto-temporo-parietal craniectomy (either unilateral or bilateral), b) the bifrontal (bicoronal) craniectomy, c) the subtemporal decompression or the recently modified temporal craniectomy, and d) the hinge (door-like) craniotomy. The fronto-temporo-parietal craniectomy (hemicraniectomy), theoretically consists of extensive bone resection, exposing practically almost the whole underlying cerebral hemisphere. The patient is placed in supine position, with his/her head turned towards the opposite direction. An extended reverse questionmark skin incision is performed starting one cm in front of the tragus, extending above and behind the ipsilateral ear (approximately to the posterior mastoid line) and then curving forward one or two cm laterally from the midline, ending at or just behind the frontal hair line. Key points of the procedure are the extension of the decompression to the floor of the middle cranial fossa (all the way to the zygomatic arch with preservation of the superficial temporal artery and the branches of the facial nerve), (Fig. 2) , and adequate size decompression with at least 12cm in its largest diameter ( Fig. 3) . Usually, the temporalis muscle is dissected in one plane (osteoplastic flap), by using monopolar cautery. According to another technique, the temporalis muscle may be mobilized separately, and its fascia may be dissected and harvested for the duraplasty. The pterion and the temporal bones have to be adequately exposed. Burr holes are placed to the pterion, temporal bone, posterior parietal and frontal regions, as close as possible to the scalp incision, taking advantage of the whole skin flap. Then, the underlying bulging dura is carefully stripped off the bone, in all the burr holes with the use of a fine dissector. The burr holes are connected by using a high-speed craniotome, and then the inferior rim of the temporal bone is carefully removed in pieces, by a large rongeur exposing thus the floor of the middle cranial fossa. At this point, the ipsilateral sphenoid wing can be drilled off, by using a diamond burr, if the patient's condition allows such a time-consuming maneuver. The bone flap may be preserved by implanting it in an abdominal subcutaneous pocket, or it can be freezed and appropriately stored. The underlying dura is incised and opened in a cruciate fashion ( Fig. 4 ). Augmentative duraplasty is performed then by using either gallea aponeurotica, or temporal fascia, or commercially available dural substitutes. The importance of performing meticulous hemostasis cannot be overemphasized. The wound is closed in anatomical layers, avoiding any tension at the skin margins. The surgeon judges according to brain edema and ICP measurements, whether the temporal fascia is sutured back or just a few approximating sutures are placed to the temporalis muscle [Apuzzo, 1993; Huang & Wen, 2010; Valadka & Robertson, 2007] . In bilateral hemicraniectomy, a bone ridge of approximately 3-4 cm in width is preserved over the superior sagittal sinus (SSS) ( Fig 5) . In bifrontal DC, a bicoronal skin flap is performed and bilateral frontal bones including the bone over the SSS are removed. A key point of this procedure is the careful elevation of the bone flap, which requires careful dissection of the underlying SSS. In the hinge craniotomy, the bone flap is repositioned in its place with the use of three titanium miniplates. A Y-shaped miniplate is placed just posterior to the coronal suture, a simple straight two-hole miniplate is placed at the sphenoid wing, and another miniplate at the posterior temporal region. It has to be emphasized, that only the Y-shaped miniplate is secured to the surrounding skull, while the other two miniplates are secured only at one side acting as buttress plates, preventing this way future bone flap settling, while allowing temporary expansion of the underlying edematous brain [Kenning, et al., 2009; Schmidt, et al., 2007] . In selected cases, DC can be combined with ipsilateral temporal lobectomy (anterior temporal lobectomy and uncusectomy), preventing thus the risk of transtentorial brain herniation. In this procedure the head of the patient should be turned 45 0 towards the contralateral side, and a fronto-temporo-parietal craniectomy is performed. After the dural incision and under microscopic magnification, an anterior temporal lobectomy is performed, sparing the superior temporal gyrus. A sub-pial aspiration/resection technique is used for removing the anterior 4-5 cm of the inferior and middle temporal gyri, as well as the fusiform gyrus, the uncus, the parahippocampal gyrus, and potentially the mesial temporal structures [Chibbaro, et al., 2008] . A decompressive craniectomy may be performed either for preventing or for treating severe brain swelling. Prophylactic or primary DC is defined as the surgical decompression performed primarily for evacuation of an underlying mass of any type, whenever the surgeon decides that removal of the bone flap along with the overlying bone flap will benefit the patient. According to the Congress of Neurological Surgeons' guidelines, a prophylactic DC may be performed in: a) comatose patients with epidural hematoma, b) in patients with acute subdural hematoma with thickness greater than 10 mm, or midline shift greater than 5 mm, c) in patients with admitting GCS score <8 and traumatic parenchymal lesions greater than 50 cm 3 in volume, or greater than 20 cm 3 with midline shift of at least 5 mm and/or cisternal compression, and d) in patients with open (compound) depressed cranial fractures, greater in thickness than that of the adjacent cranium, or with underlying hematoma, dural penetration, pneumocephalus, infection, or frontal sinus involvement [Bullock, et al., 2006; Sahuquillo & Arikan, 2006] . Secondary DC or therapeutic decompression is defined as the surgical decompression performed in patients with massive unilateral or bilateral brain edema in order to control high ICP refractory to maximal medical therapy.
Current concepts and controversies
Decompressive craniectomy has recently become a valid, widely-performed treatment option for managing patients with medically refractory intracranial hypertension. The Brain Trauma Foundation (BTF) and the Brain Injury Consortium (BIC) consider DC as a secondtier therapy for medically intractable intracranial hypertension. The algorithm of treating increased ICP of traumatic origin is based on a set of therapeutic maneuvers and first-line measures as head elevation, maintenance of adequate oxygen tension, maintenance of normovolemia and normal osmosis, normothermia, appropriate sedation and analgesia, avoiding pyrexia and seizures, adequate CSF draining via an external ventriculostomy, mild to moderate hypocapnia, administration of mannitol and hypertonic solutions, and neuromuscular blockade. When these first-level measures fail, only a few therapeutic options are available. These second-tier therapies are the administration of high dose barbiturates, induction of hypothermia, and DC. The BIC state that DC may be considered in exceptional situations, while Bullock et al suggest that DC may be the procedure of choice in patients with post-traumatic edema, hemispheric swelling, or diffuse injury given the appropriate clinical context. This context however, remains to be defined [Brain Trauma Foundation [BTF], 2007; Bullock, et al., 2006; Maas, et al., 1997] . Numerous experimental models have demonstrated that DC reduces secondary brain injury. These effects are thought to be the result of an increase in collateral cerebral circulation, reduction in tissue edema, and improvement in oxygenation and energy metabolism [Stiver, 2009; Weiner et al., 2010] . Furthermore, postoperative radiological evaluation in cases of DC shows amelioration of midline shift, and improvement of the preoperative compression of the basal cisterns [Laalo, et al., 2009] . Despite the constantly increasing clinical employment of DC in the management of patients with S-TBIs, there are still several points of controversy, regarding its exact role in the treatment of these patients. The most important controversial points may be summarized to the following:  Lack of clear indications and guidelines, regarding the selection of candidates for DC. Cochrane data base analysis in 2007 [Sahuquillo & Arikan, 2006] concluded that there was no evidence to support the routine use of secondary DC to reduce unfavorable outcome in adults suffering S-TBIs and refractory intracranial hypertension. Contrariwise, it seems that there is more solid evidence in pediatric trauma patients, in whom DC seems to reduce the risk of death and unfavorable outcome [Sahuquillo & Arikan, 2006 before irreversible brain stem compression and/or herniation occur [Ruf, et al., 2003; Timofeev, et al., 2008] .  Ideal size of decompression. It was previously mentioned that adequate decompression of the floor of the middle cranial fossa is essential for achieving optimal relaxation of the perimesencephalic cisterns. It has been also proven that small DCs and small dural openings may cause swollen brain tissue to herniate through the bony defect, causing strangulation, infarction and worsening of the brain swelling. The current trend is to perform large size DCs with a diameter larger than 12 cm. However, the issue of the appropriate size DC has to be addressed in a prospective, randomized study. 
The exact role of other parameters of neuromonitoring, such as brain tissue oxygen, markers of anaerobic metabolism (microdialysis), transcranial Doppler ultrasonography measurements, and electroencephalographic monitoring may provide further information, making the selection of ideal surgical candidate for DC more accurate [Bor-Seng-Shu, et al., 2006; Weiner, et al., 2010] . 
The effect of DC in the functional outcome of patients with S-TBIs remains to be proven. Does the performance of DC provide better functional outcome? Several clinical studies have suggested that DC reduces ICP but the overall functional outcome remains essentially unchanged [Danish, et al., 2009; Howard, et al., 2008; Morgalla, et al., 2008] . During the last decade a systematic attempt was made to prospectively assess the role of DC in the management of patients suffering S-TBIs and/or presenting medically refractory intracranial hypertension [Ban, et al., 2010; Morgalla et al., 2008; Valadka & Robertson, 2007] .Two independent, parallel, multi-centric, prospective clinical studies (the DECRA and the Rescue ICP trials) were designed and are underway for evaluating the exact role of DC in the management of patients with S-TBIs. These studies are supposed to address the issue of the efficacy of DC but also may clarify other DC-associated controversial points.
The DECRA clinical trial
The early DEcompressive CRAniectomy (DECRA) in patients with severe traumatic brain injury is a multi-centric, prospective, randomized trial, coordinated by The National Trauma Research Institute, the National Health and Medical Research Council of Australia, the Victorian Trauma Foundation, the ANZICS Foundation, and the Western Australian Institute for Medical Research. The primary objective of the trial is to determine whether early decompressive craniectomy compared to conventional management strategies in patients with severe diffuse traumatic brain injury and early refractory intracranial hypertension improves neurological outcomes, at six months post injury. The inclusion criteria are: severe diffuse traumatic brain injury defined as GCS<9 and CT-scan with evidence of brain swelling (Marshall score grade D2-4), or GCS score > 8 before intubation and Marshall score D3 or D4 on the obtained brain CT scan, age 15-60 years, ICP monitor insertion, decompression within 72 hours from the injury, and medically refractory ICP (defined as ICP> 20mmHg for more than 15 minutes continuously or cumulative during one hour) [Cooper, et al., 2008] . The exclusion criteria are: intracranial hemorrhage>3cm in diameter, intracranial mixed hemorrhagic contusion>5cm in long axis, previous craniectomy, presence of epi-dural and/or sub-dural hematoma > 0.5 cm in thickness, co-existent spinal cord injury, penetrating brain injury, arrest at the scene, unreactive pupils >4mm in diameter, GCS score =3, general contraindications for neurosurgical intervention, or no change of survival after careful consideration of the obtained brain CT and the patient's clinical examination.
The surgical technique used is the bifrontal decompressive craniectomy (as described by Polin and his coworkers) with a single fronto-temporal bone flap extending across the midline. The underlying dura could be opened either by making a bilateral cruciate incision or by employing a large L-shaped incision, with the lower corner of the L facing laterally. The dural openings are covered with dural or fascial patches [Polin, et al., 1997] . DECRA trial investigators presented their initial results in April 2011. They reported on 155 randomly assigned cases (73 patients underwent DC while 82 had standard care). According to their results the investigators concluded that in adults with severe diffuse traumatic brain injury and refractory intracranial hypertension, early bifronto-temporo-parietal decompressive craniectomy decreased intracranial pressure and the length of stay in the ICU. However, they found that patients undergoing craniectomy had worse scores on the Extended Glasgow Outcome Scale than those receiving standard care (odds ratio for a worse score in the craniectomy group: 1.84). Similarly, patients undergoing DC demonstrated a greater risk of an unfavorable outcome (odds ratio: 2.21). The observed death rates at six months were similar in the craniectomy group (19%) and the standard-care group (18%) [Cooper, et al., 2011] . It has to be emphasized however, that the DECRA study carries significant weaknesses and biases. It is of great interest that out of 3700 patients, who were potential candidates for participating in this study, only 155 were finally recruited. This may be a significant selection bias. In addition, the small number of study participants significantly decreases the statistical strength of the DECRA study. Furthermore, the utilized ICP threshold of 20 mmHg for assigning patients for DC may be considered too low for patients with S-TBIs.
The rescue ICP trial
The Randomized Evaluation of Surgery with Craniectomy for Uncontrollable Elevation of Intra-Cranial Pressure, is a multi-centric 48 (centers from 19 different countries) clinical study, organized as a collaborative research project between the university of Cambridge (Departments of Neurosurgery and Neurointensive Care), and the European Brain Injury Consortium. It is a randomized controlled trial comparing the efficacy of DC versus optimal medical management for the treatment of refractory intracranial hypertension following brain trauma. The inclusion criteria are: patients with S-TBI, age 10-65 y.o, with an abnormal CT-scan requiring ICP monitoring, and raised ICP > 25 mmHg for > 1 hour to 12 hours. Patients may have immediate operation for a mass lesion but not a decompressive craniectomy. Patients with immunological, hepatic, or renal compromise may be included in this study as long as there is a description of the type and the extent of their impairment. Contrariwise, patients with bilateral fixed and dilated pupils, bleeding diathesis, a devastating injury, inability to follow them, inability to monitor ICP, primary decompression, brainstem injury, or patients that were treated according to the Lund protocol, or have received barbiturates before their randomization, should be excluded from the study. The surgical treatment comprises of a large unilateral fronto-temporo-parietal craniectomy for unilateral brain edema or of large bilateral fronto-temporo-parietal craniectomies for diffuse bilateral hemisphere swelling. The craniectomy extends from the frontal sinus anteriorly to the coronal suture posteriorly, and to the pterion laterally. It is accompanied by a large dural opening (dural flap pedicles are based on the superior sagittal sinus medially, and also a division of the falx anteriorly is required). The primary endpoint of the Rescue-ICP study will be the outcome assessment at discharge (GOS score), and then at six months after injury (Extended GOS score), while secondary endpoints will be: a) the assessment of outcome using the SF-36 and the SF-10 questionnaires, b) assessment of ICP control, c) length of stay in the ICU, d) hospital length of stay, and e) a detailed health-economic analysis of the collected data [Hutchinson, et al., 2006 ] . The results of the Rescue-ICP study are expected with great interest, and may greatly influence the future of DC and the overall management of patients suffering S-TBIs.
Decompressive craniectomy complications
Decompressive craniectomy has been associated with high mortality rates, mainly due to the severity of the underlying trauma, and also with numerous, and occasionally severe complications. Several factors have been identified as predisposing to the development of DC-associated complications. These include low GCS score upon admission, patient's old age, the presence of commorbidity, and the systematic preoperative anti-coagulant administration. Yang et al [Yang, et al., 2008] reported that the frequency of DC associated complications was 62% for admitting GCS scores 3-5, 39% for GCS scores 6-9, and 36 % for GCS scores >9. In addition, older patients (> 60 y.o) tend to have higher complications rates and prolonged ICU stay. Likewise, preoperative administration of anti-coagulant or antiplatelet medication increases the risk of intraoperative and/or postoperative bleeding. The alterations in cerebral compliance, CBF autoregulation, and altered CSF dynamics associated with S-TBIs, are the main reason for developing DC-associated complications. Several theories suggesting that the sudden change from prolonged severe compression to a state of maximal vasolidation and hyperemia following DC may cause loss of autoregulation, and may be responsible for the occurrence of DC associated complications [Aarabi, et al., 2009; Yang, et al., 2008] . The most commonly occurred complications may be divided to:
Perioperative complications
a. Blossoming of pre-existing cerebral contusions. Expansion of pre-existing hemorrhagic contusions, as demonstrated on serial CT scans, has been reported as frequently as 40% of the cases, and may be considered inherent to the injury evolving process. b. Evolution and expansion of contralateral masses. The decompression provided by DC allows the expansion of contralateral masses (hematomas), which that were preoperatively tamponated by the swollen brain. c. External cerebral herniation. Expansion of the edematous brain through the bony defect may occur, especially during the first two postoperative weeks. The compression of the cortical veins of the herniated cerebral tissue leads to infarction, and unfortunately to further swelling. In small size decompressions, a mushroom-like herniation of the swollen parenchyma may occur. Therefore, most surgeons propose large craniectomies and wide dural openings for protecting the underlying cortical veins and for minimizing the risk of external cerebral herniation.
Early postoperative complications.
a. Subdural effusions and hygromas are very often developed in cases of DC (Fig 6) . Aarabi and his coworkers [Aarabi, et al., 2009] have reported subdural effusions and hygromas in 50% of their cases. Alteration of CSF circulation after a DC may incite the development of hygromas, which may progressively expand in volume. However, the hygromas very rarely demand surgical evacuation, and they usually resolve spontaneously. b. Impaired wound healing and infection may complicate a DC, and prolong patient's hospitalization. The performance of an extensive DC may compromise the skin flap blood supply (especially in the occipital area), and thus may increase the possibility of postoperative wound healing problems. Therefore, it is of paramount importance to maintain adequate skin flap blood supply by preserving the superficial temporal artery, and by avoiding tight skin suturing during closure. The observed high infection rate in patients undergoing DC may also be partially explained by the fact that the vast majority of these patients require prolonged ICU treatment and multiple interventions. c. Post-DC hydrocephalus incidence has been reported to be as high as 15 %, and is associated with poorer clinical outcome (Fig 7) . The treatment of hydrocephalus with CSF shunting remains controversial, and the timing of intervention before or after cranioplasty is still disputable. d. The syndrome of the trephined is a frequent delayed complication and its diagnosis is often overlooked. Occasionally it may be presented with delayed onset of focal neurological deficits. e. Paradoxical herniation with brain stem compression and neurological deterioration is a very rare complication and may be precipitated by a lumbar puncture in a craniectomized patient.
Cranioplasty
One of the drawbacks of DC is the fact that a second surgical intervention is required to repair the bone defect. Autologous bone grafts may be used, which are preserved subcutaneously, or stored freezed under specific conditions in storage bone-banks. Tailormade heterologous or synthetic bone grafts may also be used. The previous belief ofdelayed cranioplasty for minimizing the risk of infection, is seriously questioned nowadays, and an increasing number of surgeons prefer early surgical skull reconstruction. Several surgeons support the idea of immediate cranioplasty even during the initial hospitalisation, as early as 2-4 weeks after trauma, when there is no suspicion of infection. The possibility of a new head injury with the exposed brain unprotected must be taken into consideration. Moreover, the observation of better functional outcome after cranioplasty, may further increase the number of early cranioplasty cases [Beauchamp, et al., 2010; Morina, et al., 2011] .
Conclusions
The management of refractory post-traumatic intracranial hypertension remains a challenge for neurosurgeons, anesthesiologists, and neuro-intensivists. Cerebral ischemia leading to severe disability or death is unfortunately the only result expected. In order to deal with this dramatic situation only few treatment options exist. The ultimate measure to relieve uncontrollable ICP is an extensive decompressiv e c r a n i e c t o m y . I t i s p r o v e n t h a t D C increases the volumetric compensatory capacity and reduces ICP. However, the welldocumented risks and drastically complications of DC have to be seriously considered before performing a DC. In carefully selected cases these risks may be outweighted by the expected benefit. The results of the two ongoing prospective, randomized, controlled trials are expected to enlighten us on the exact role of DC in the management of patients with S-TBIs, and its effect on their long-term functional outcome.
